A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

NCT05721287 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Acute Pain

Interventions

DRUG: SBS-1000
DRUG: Placebo

Sponsor

Sparian Biosciences, Inc